|
ZNF468 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.148330E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.574200E-02 |
| Normal-vs-Stage2 |
7.146800E-01 |
| Normal-vs-Stage3 |
7.982000E-04 |
| Normal-vs-Stage4 |
5.202700E-03 |
| Stage1-vs-Stage2 |
3.931000E-01 |
| Stage1-vs-Stage3 |
3.252300E-02 |
| Stage1-vs-Stage4 |
1.164390E-01 |
| Stage2-vs-Stage3 |
5.362400E-02 |
| Stage2-vs-Stage4 |
6.452000E-02 |
| Stage3-vs-Stage4 |
8.013400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.362500E-03 |
| Normal-vs-AfricanAmerican |
3.355300E-04 |
| Normal-vs-Asian |
9.529200E-01 |
| Caucasian-vs-AfricanAmerican |
3.175800E-02 |
| Caucasian-vs-Asian |
3.561700E-02 |
| AfricanAmerican-vs-Asian |
2.539500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.504100E-03 |
| Normal-vs-Female |
3.882400E-02 |
| Male-vs-Female |
1.013360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.898200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.939000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.132180E-02 |
| Normal-vs-Age(81-100Yrs) |
2.465700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.080400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.686200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.859000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.381600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.611200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.847000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.207250E-01 |
| Classical-VS-Follicular |
8.542200E-01 |
| Classical-VS-Other |
1.970360E-01 |
| Classical-VS-Normal |
4.066000E-02 |
| Tall-VS-Follicular |
2.295400E-01 |
| Tall-VS-Other |
3.413400E-01 |
| Tall-VS-Normal |
7.118200E-03 |
| Follicular-VS-Other |
1.039830E-01 |
| Follicular-VS-Normal |
2.417600E-01 |
| Other-VS-Normal |
1.811790E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.310500E-02 |
| Normal-vs-N1 |
1.675840E-02 |
| N0-vs-N1 |
3.861000E-01 |
|
|
